Non‐surgical management vs active treatment in T1a renal cell carcinoma: a population‐based study

To compare overall and cancer‐specific survival for clinical (c)T1aN0M0 renal cell carcinoma (RCC) in patients treated with non‐surgical management (NSM: surveillance and watchful waiting) or active treatment (surgery and ablative treatments).

• Publication year

  2025

• Venue

  BJU International

• Publication date

  2025-11-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bju.70074PMID 41230913PMCID 12789845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update.

  2025cited by this paper
• Healthcare costs in relation to increased use of preoperative renal tumour biopsies.

  2025cited by this paper
• Rate of benign histology after resection of suspected renal cell carcinoma: multicenter comparison between Korea and the United States

  2024cited by this paper
• Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis

  2024cited by this paper
• Diagnostic accuracy and safety of renal tumour biopsy in patients with small renal masses and its impact on treatment decisions.

  2024cited by this paper
• Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative Analysis.

  2024cited by this paper
• Thermal ablation vs. active surveillance for renal masses: a systematic review and network meta-analysis.

  2023cited by this paper
• Canadian Urological Association guideline: Management of small renal masses - Full-text.

  2022cited by this paper
• Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma – results from the National Swedish Kidney Cancer Register

  2022cited by this paper
• Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: a systematic review.

  2021cited by this paper
• The renal cell cancer database Sweden (RCCBaSe) – a new register-based resource for renal cell carcinoma research

  2020cited by this paper
• Comparison of survival benefits of nephron-sparing intervention or active surveillance for patients with localized renal masses: a systematic review and meta-analysis

  2019cited by this paper
• Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of renal mass biopsy in the management of kidney cancer.

  2019cited by this paper
• A real-world study of socioeconomic factors with survival in adults aged 18-64 years with renal cell carcinoma.

  2019cited by this paper
• Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.

  2018cited by this paper
• Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma

  2016cited by this paper
• Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.

  2015cited by this paper
• Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate.

  2015cited by this paper
• The association between socioeconomic status, renal cancer presentation, and survival in the United States: a survival, epidemiology, and end results analysis.

  2014cited by this paper
• Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older

  2010cited by this paper
• Abbreviations

  2009cited by this paper
• A population‐based comparison of survival after nephrectomy vs nonsurgical management for small renal masses

  2009cited by this paper
• Social inequality and incidence of and survival from cancers of the kidney and urinary bladder in a population-based study in Denmark, 1994-2003.

  2008cited by this paper
• Five‐year survival after surgical treatment for kidney cancer

  2007influential reference
• Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data

  2005cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987influential reference
• Results

  1969cited by this paper

• No citing papers are available for this paper.